A comparison of two modalities of stereotactic body radiation therapy for peripheral early-stage non-small cell lung cancer: results of a prospective French study.
Journal
The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125
Informations de publication
Date de publication:
01 Dec 2020
01 Dec 2020
Historique:
pubmed:
25
9
2020
medline:
15
12
2020
entrez:
24
9
2020
Statut:
ppublish
Résumé
This prospective, observational, non-randomized multicentric study was conducted to compare efficiency and toxicity using different modalities of stereotactic body radiation therapy (SBRT) in early-stage peripheral non-small cell lung cancer (NSCLC). From 9 April to 11 December, 106 patients were treated according to the local equipment availability for peripheral NSCLC with SBRT: 68 by linear accelerator equipped for SBRT and 38 by Cyberknife 2-year local control rates were 97.0% (95% CI: [90.6%; 99.4%]) with SBRT by Linac No difference in efficiency or toxicity was shown after SBRT of peripheral NSCLC treatment using Linac or Cyberknife This is the first large prospective non-randomized study focusing on peripheral localized NSCLC comparing SBRT using an appropriately equipped linac with Cyberknife
Identifiants
pubmed: 32970478
doi: 10.1259/bjr.20200256
pmc: PMC7716015
doi:
Types de publication
Comparative Study
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
20200256Références
Int J Technol Assess Health Care. 2014 Jul;30(3):325-32
pubmed: 25148300
J Clin Epidemiol. 2006 May;59(5):437-47
pubmed: 16632131
J Radiat Oncol. 2015;4(1):55-63
pubmed: 25774243
Br J Cancer. 1977 Jan;35(1):1-39
pubmed: 831755
Front Oncol. 2012 Feb 01;2:9
pubmed: 22655258
J Thorac Dis. 2018 Aug;10(8):4976-4984
pubmed: 30233872
Chest. 2003 Nov;124(5):1946-55
pubmed: 14605072
Transl Lung Cancer Res. 2017 Feb;6(1):6-13
pubmed: 28331819
Clin Oncol (R Coll Radiol). 2009 Oct;21(8):623-31
pubmed: 19682875
Radiother Oncol. 2009 Jun;91(3):296-300
pubmed: 19297048
Med Oncol. 2015 Mar;32(3):55
pubmed: 25638468
Stat Med. 2005 Oct 30;24(20):3089-110
pubmed: 16189810
J Thorac Dis. 2019 Jan;11(1):214-221
pubmed: 30863591
Clin Lung Cancer. 2017 Mar;18(2):105-121.e5
pubmed: 27908621
J Radiat Oncol. 2016;5(4):379-387
pubmed: 28018523
Mol Clin Oncol. 2015 Mar;3(2):442-448
pubmed: 25798283
Technol Cancer Res Treat. 2015 Dec;14(6):667-76
pubmed: 24988054
J Hematol Oncol. 2009 Jan 17;2:1
pubmed: 19149899
J Clin Oncol. 2009 Jul 10;27(20):3290-6
pubmed: 19414667
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1343-9
pubmed: 20708849
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96
pubmed: 26581137
Stat Med. 1999 Mar 30;18(6):695-706
pubmed: 10204198
Radiother Oncol. 2015 Oct;117(1):44-8
pubmed: 26492839
Lung Cancer. 2017 Jan;103:6-10
pubmed: 28024698
JAMA. 2010 Mar 17;303(11):1070-6
pubmed: 20233825
Value Health. 2010 Mar-Apr;13(2):273-7
pubmed: 19912596
Comput Methods Programs Biomed. 2004 Jul;75(1):45-9
pubmed: 15158046
Stat Sci. 2010 Feb 1;25(1):1-21
pubmed: 20871802
Br J Radiol. 2016 Dec;89(1068):20160560
pubmed: 27805837
Lung Cancer. 2015 Dec;90(3):388-96
pubmed: 26791797